Natco Pharma Ltd has received approval from the US Food and Drug Administration for its abbreviated new drug application for Lansoprazole delayed release capsules for the prescription market. The drug is indicated for the treatment of gastric (stomach) ulcers. Shipments of the product will commence immediately, the Hyderabad-based company said in a release.

(This article was published on December 19, 2012)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.